摘要
自1995年发现脂联素以来,其对心血管病和糖尿病病理方面的作用已引起极大关注。脂联素是源于脂肪组织的激素,已显示其具有抗动脉硬化特性,主要有三个方面作用:脂联素对内皮功能、对动脉炎症及动脉血管重构的作用。
出处
《中国老年学杂志》
CAS
CSCD
北大核心
2013年第2期488-490,共3页
Chinese Journal of Gerontology
二级参考文献87
-
1Purushotham A, Wendel AA, Liu LF, Belury MA. Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice. J Lipid Res 2007; 48: 444–52.
-
2Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002; 143: 998–1007.
-
3Mullen KL, Pritchard J, Ritchie I, Snook LA, Chabowski A, Bonen A, et al. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 2009; 296: R243–51.
-
4Bruce CR, Mertz VA, Heigenhauser GJ, Dyck DJ. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 2005; 54: 3154–60.
-
5Dietze-Schroeder D, Sell H, Uhlig M, Koenen M, Eckel J. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 2005; 54: 2003–11.
-
6Fiaschi T, Buricchi F, Cozzi G, Matthias S, Parri M, Raugei G, et al. Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin. Hepatology 2007; 46: 130–9.
-
7McAinch AJ, Steinberg GR, Mollica J, O'Brien PE, Dixon JB, Macaulay SL, et al. Differential regulation of adiponectin receptor gene expression by adiponectin and leptin in myotubes derived from obese and diabetic individuals. Obesity (Silver Spring) 2006; 14: 1898–904.
-
8Kim CH, Pennisi P, Zhao H, Yakar S, Kaufman JB, Iganaki K, et al. MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness. Am J Physiol Endocrinol Metab 2006; 291: E298–305.
-
9Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, et al. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 2007; 56: 1969–76.
-
10Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004; 279: 30817–22.
共引文献8
-
1Carmine Finelli,Giovanni Tarantino.What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?[J].World Journal of Gastroenterology,2013,19(6):802-812. 被引量:30
-
2Alex F CHEN,Chao-shu TANG.Frontiers of vascular biology and disease research[J].Acta Pharmacologica Sinica,2010,31(10):1241-1242.
-
3刘健,李群芳,吴洁.脂联素对冠心病患者的保护作用研究进展[J].中国医药指南,2011,9(24):6-6. 被引量:1
-
4丁铭格,李榕,王晓明.LDL-C边缘升高患者血清ONOO^-、脂联素及TNF-α的变化[J].临床心血管病杂志,2012,28(1):51-53. 被引量:1
-
5周绍霞,刘煜敏,李芹,谢玉,孔朝红,程仙送.脂联素在糖尿病大鼠脑缺血再灌注损伤中的表达及其影响[J].中华神经医学杂志,2014,13(1):30-35. 被引量:2
-
6马非凡,刘滨,李悦,刘广忠.脂联素与冠心病的研究进展[J].心血管病学进展,2015,36(1):80-83. 被引量:16
-
7陈婧,杨惠民,叶超,薛晓琳.血脂异常不同证候间患者血浆ONOO^-、D-二聚体特点及其与血脂指标典型相关性分析[J].中华中医药杂志,2015,30(5):1704-1707. 被引量:5
-
8石俊婷,张敏莉,魏洪杰,朱铭,芦涤.抗抑郁治疗对AMI合并抑郁患者PCI术后血清脂联素的影响[J].医学与哲学(B),2015,36(6):30-31. 被引量:4
同被引文献88
-
1中国髙血压防治指南修订委员会.中国高血压防治指南:2010年修订版[M].北京:人民卫生出版社,2010.
-
2lnadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems[J ]. Int J Med Sci, 2008, 5(5): 248.
-
3Inadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems[J]. Int J Med Sci, 2008,5(5) :248.
-
4Marso SP,Mehta SK,Frutkin A. Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabedc coronary arteries[J].DIABETES CARE,2008,(05):989.
-
5Yamauchi T,Kamon J,Ito Y. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J].NATURE,2003,(6941):762-769.
-
6周颖;陈虹.高血压动物模型研究进展[J]中国现代实用医学杂志,200651-53.
-
7Iwashima Y,Katsuya T,Ishikawa K. Hypoadiponectinemia is an endependent risk factor for hypertemion[J].HYPERTENSION,2004.1318-1324.
-
8Matsuda M,Shimomura I,Sata M. Role of adiponectin in preventing vascular stenosis.The missing link of adipo-vascular axis[J].Biological Chemistry,2002.37487-37491.
-
9Tsuchida A,Yamauchi T,Ito Y. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity[J].Journal of Biological Chemistry,2004,(29):30817-30822.
-
10Fasshaner M,Pasehke R,Stumvoll M. Adiponectin,obesity,and cardlovascular disease[J].Biochimie,2004,(11):779.
引证文献8
-
1方惠霞,黎瑞莲,吴恩平,屈丸,赖祥青,方海燕.动脉硬化检测和颈动脉超声多普勒联合检查对动脉硬化的诊断价值[J].中国老年学杂志,2015,35(2):396-397. 被引量:8
-
2汪兰君,陈少明.不同降压药对高血压伴糖尿病治疗效果的对比观察[J].中国当代医药,2013,20(21):68-69. 被引量:6
-
3孙蕊,孙红茜,刘雅娟,秦毅,杨锐英.自发性高血压大鼠脂联素及其受体1的表达与心血管重构的关系[J].宁夏医学杂志,2014,36(1):3-7.
-
4杨永碧.血清脂联素在妊娠期高血压疾病中的变化及其与胰岛素抵抗的关系[J].实用临床医药杂志,2014,18(3):124-126. 被引量:4
-
5杨永碧.血清脂联素在妊娠期高血压疾病中的变化及其与胰岛素抵抗的关系[J].华南国防医学杂志,2014,28(4):340-342. 被引量:4
-
6邹燕,刘翠中,汪雁归.缬沙坦对冠心病患者脂联素和血管内皮功能的影响[J].疑难病杂志,2014,13(7):665-667. 被引量:3
-
7李青,刘文莉,帖丽丽,李扬.老年高血压患者血清抵抗素及脂联素水平的相关性研究[J].实用老年医学,2016,30(11):906-908. 被引量:6
-
8郭岩,王娟.针刺配合西药治疗急性脑梗死疗效和对患者脂联素、hs-CRP及颈动脉斑块的影响[J].陕西中医,2018,39(11):1627-1629. 被引量:7
二级引证文献38
-
1徐立,陈刚,张友章.卡托普利联合硝苯地平治疗2型糖尿病合并高血压的临床分析[J].中国医药,2014,9(4):506-508. 被引量:21
-
2张淑芳,于易,田晓蕾,陈梅.妊娠糖尿病患者血清脂联素水平变化及其与炎症因子胰岛素抵抗的关系[J].河北医学,2015,21(2):272-275. 被引量:23
-
3韦德标,钟友凤,刘丽玉.缬沙坦、氨氯地平联合用药对社区老年高血压伴2型糖尿病患者血压和血糖控制的影响[J].临床医学工程,2015,22(12):1603-1604. 被引量:7
-
4陈颖.妊娠糖尿病患者血清脂多糖、蛋白质核因子-κB、可溶性细胞间黏附分子-1、脂联素水平变化及意义[J].中国临床医生杂志,2016,44(5):88-90. 被引量:3
-
5关巍.卡托普利在糖尿病并发症中的应用[J].中国实用医药,2016,11(12):285-286. 被引量:2
-
6邵光,胡春玲,吴喜才.妊娠糖尿病患者脂联素水平及其与胰岛素抵抗的相关性分析[J].深圳中西医结合杂志,2016,26(10):3-4.
-
7韩秀英,杜咏梅,付金国.老年原发性高血压患者血清脂联素水平与胰岛素抵抗的相关性研究[J].医学临床研究,2016,33(7):1405-1407. 被引量:7
-
8平虎,汤进,蒲燕,刘波.血清皮质醇、脂联素、一氧化氮等水平与老年急性创伤患者预后的关系[J].疑难病杂志,2016,15(8):821-824. 被引量:8
-
9杜文婷,刘萍.颈动脉超声检测在心脑血管疾病中的应用概况[J].中西医结合心脑血管病杂志,2016,14(10):1117-1120. 被引量:9
-
10刘婷,曾玉玲,林肖彬.动脉硬化检测仪检测和联合颈动脉超声多普勒检查对动脉硬化诊断的效果比较[J].包头医学院学报,2016,32(11):90-91. 被引量:1
-
1王玉倩,葛久欣,吴爱丽,姜春艳,刘雨晶.瑞舒伐他汀治疗高血压骨质疏松症患者的研究[J].黑龙江医学,2013,37(4):271-272.
-
2孙丽霞.低分子肝素联合阿托伐他汀钙治疗合并糖尿病的不稳定性心绞痛疗效观察[J].现代医药卫生,2010,26(5):742-743. 被引量:2
-
3闫胜敏,李拥军.原发性高血压与脂联素、C反应蛋白关系及机制的研究进展[J].临床合理用药杂志,2011,4(7):145-146. 被引量:5
-
4杨阳,李平.三七粉对原发性高血压病患者的疗效观察[J].中医临床研究,2017,9(3):29-30. 被引量:8
-
5任忠法,薛现中,官庆波.2型糖尿病患者抗动脉粥样硬化的临床研究进展[J].医学综述,2009,15(11):1696-1698. 被引量:5
-
6滕雅秋,林旭荣.急性冠脉综合征患者CRP、IL-6的变化及阿托伐他汀钙对其影响[J].中国实用医药,2011,6(12):168-169.
-
7张磊,周建,王剑楠,景在平.巨噬细胞参与主动脉血管重构的机制研究进展[J].中华外科杂志,2013,51(2):179-181. 被引量:1
-
8流霜.联合使用他汀类药物和雌激素可最大限度使绝经后心血管受益[J].中华医学信息导报,2002,17(9):18-18.
-
9金焱.06021 普伐他汀可降低CRP水平[J].国外药讯,2001(6):12-12.
-
10王金良.帮您分析化验单(11) 低密度脂蛋白胆固醇含量多少为正常[J].开卷有益(求医问药),2007(11):17-17.